TyG Index and Risk of Stroke: A Systematic Review and Meta-analysis
A systematic review and meta-analysis of 21 studies reveals that individuals in the highest quartiles of the Triglyceride-Glucose (TyG) index,TyG-BMI,TyG-Waist Circumference (WC),and TyG-Waist-to-Height Ratio (WHtR) exhibit an increased risk of stroke compared to those in the lowest quartile. subgroup analysis indicated that this association remained consistent across gender, region, sample size, and follow-up duration.
This study builds upon previous research demonstrating a positive correlation between the TyG index and stroke. It represents the first meta-analysis specifically examining the association between TyG-BMI, TyG-WC, TyG-WHtR and stroke risk. The inclusion of more recent studies and a focus on cohort studies – utilizing Hazard Ratios (HR) to account for time-dependent effects and mitigate recall bias – enhance the precision and reliability of the findings.
The increased stroke risk associated with high TyG quartiles is highly likely linked to insulin resistance (IR), a key factor in stroke pathogenesis. IR triggers a cascade of events including vasoconstriction, vascular smooth muscle cell proliferation, and increased blood pressure via MAPK activation. it also promotes inflammation, damages vascular endothelial cells, and disrupts glucose and lipid metabolism, leading to atherosclerotic plaque formation. Furthermore, IR induces endoplasmic reticulum stress in macrophages, contributing to plaque rupture and thrombosis, and is associated with hyperfibrinogenemia and platelet aggregation.
The study also found a higher stroke risk in the highest quartiles of TyG-BMI, TyG-WC, and tyg-WHtR. Combining the TyG index with obesity indices (BMI, WC, WHtR) provides a more thorough assessment of IR than individual indices alone. Thes combined indices, reflecting both insulin sensitivity and visceral adiposity, demonstrate a stronger association with IR and cardiovascular risk, possibly through chronic inflammation and vascular endothelial injury.
While sex hormones may influence IR, gender differences were observed in this meta-analysis. High TyG and TyG-BMI parameters were more predictive of stroke risk in men, whereas high TyG-WC and TyG-WHtR parameters were less predictive. Further research is needed to fully elucidate the reasons behind these gender-specific findings.
The TyG Index as a Stroke Risk Biomarker: Current Understanding and Future Directions
The Triglyceride-Glucose (TyG) index is emerging as a potentially valuable biomarker for identifying individuals at increased risk of stroke and cardiovascular disease. Derived from readily available clinical measurements – triglyceride levels and fasting glucose – the TyG index offers a simple and inexpensive method for assessing metabolic health and predicting adverse outcomes. However, interpreting its clinical meaning requires careful consideration of existing limitations and ongoing research.
What is the TyG Index?
The TyG index is calculated using the formula: ln(Triglycerides (mg/dL) × Fasting Glucose (mg/dL) / 2). It reflects insulin resistance (IR), a key factor in the development of atherosclerosis and subsequent cardiovascular events, including stroke. Elevated TyG index values are generally associated with increased IR and a higher risk of metabolic disorders.
Evidence Linking TyG to Stroke Risk
Multiple studies, including meta-analyses, have demonstrated a positive association between higher TyG index values and an increased risk of stroke. A dose-response analysis of 19 cohort studies by Yan et al. found that each 1 mg/dL increase in the TyG index corresponded to a 1.19-fold increase in the risk of cerebrovascular disease,highlighting its value as a continuous risk indicator.
Challenges and Limitations in Current Research
Despite promising findings, several factors complicate the interpretation of existing research on the TyG index and stroke risk:
* Heterogeneity of Studies: Meta-analyses combining data from various studies are hampered by inconsistencies in sample sizes, follow-up durations, and the populations studied. This variability introduces heterogeneity, making it difficult to draw definitive conclusions.
* Confounding Factors: Numerous factors can influence both the TyG index and stroke risk, potentially distorting observed associations. These include:
* Comorbidities: Underlying health conditions like diabetes,hypertension,and othre cardiovascular risk factors can independently affect stroke risk.
* Medications: Drugs commonly used to manage cardiovascular risk, such as statins, antihypertensives, and antidiabetic agents (like metformin), can influence stroke risk independently of the TyG index. Research suggests pre-stroke metformin use is associated with reduced mortality and improved functional outcomes. This suggests the TyG index may be most useful in identifying patients who would benefit from such interventions.
* Lifestyle Factors: Diet and other lifestyle choices can impact both insulin resistance and stroke risk.
* Inflammation: Chronic inflammation, closely linked to IR and atherosclerosis, is a potential confounding variable.
* Analytical Variability: Differences in laboratory methods used to measure triglycerides and fasting glucose – including variations in reagents and instruments – can affect the accuracy and comparability of tyg index calculations.
* Stroke Subtype Definitions: Studies vary in their definitions of stroke, with some focusing solely on ischemic stroke while others include hemorrhagic stroke or all stroke subtypes. This inconsistency impacts the generalizability of findings.
Optimal Thresholds for Stroke Risk Prediction
Currently, there is no universally accepted optimal threshold value for the TyG index to predict stroke risk. Suggested cut-off points vary based on population and health status:
* General Population: Studies suggest a TyG index > 8.81 in men and > 8.73 in women may indicate insulin resistance.
* Hypertensive Patients: Thresholds for all-cause mortality risk have been suggested at 9.75 (general hypertensive population) and even lower at 9.45, suggesting comorbidity influences risk assessment. The NHANES cohort identified a TyG threshold of 9.52 for cardiovascular mortality risk in hypertensive patients.
* Critically Ill Patients: The tyg-BMI threshold can increase considerably in critically ill patients, reaching 269 in those with respiratory failure, demonstrating the impact of disease severity on metabolic indicators.
Future Research Directions
To maximize the clinical utility of the TyG index, future research should focus on:
* Investigating Confounding factors: Further studies are needed to assess the impact of race, region, medications, inflammation, and other potential confounders on the relationship between the TyG index and stroke risk.
* Establishing Optimal Thresholds: Research should aim to determine optimal TyG index cut-off values for stroke risk prediction, tailored to specific populations, comorbidities, and disease severity.
* Exploring Individualized Treatment Strategies: Investigating the interaction between the TyG index and antidiabetic drugs, like metformin, could pave the way for personalized treatment approaches to improve metabolic control and reduce stroke risk in high-risk individuals.
* Integration into Risk Assessment Tools: The TyG index has the potential to be incorporated into comprehensive risk assessment tools to enhance stroke prediction, given its simplicity, low cost, and association with metabolic disease risk.
Disclaimer: This data is for general knowledge and informational purposes only, and does not constitute medical advice.It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Sources: (Based on information provided in the original text and supplemented with current research)
* Yan, et al. (2023). Dose-response analysis of the triglyceride